3A-register for outpatient therapy with RAS inhibitors in patients with arterial hypertension in Germany [3A-Register Zur Ambulanten Therapie Mit RAS-Inhibitoren in Patienten Mit Arterieller Hypertonie in Deutschland]
Phase of Trial: Phase IV
Latest Information Update: 20 Apr 2016
At a glance
- Drugs Aliskiren (Primary) ; ACE inhibitors; Angiotensin receptor antagonists; Antihypertensives
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms 3A Registry
- 20 Apr 2016 Results (retrospective analysis, n = 3772) assessing aliskiren in diabetic patients published in the Journal of Clinical Hypertension (Greenwich).
- 21 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Oct 2011 New trial record